 | | TH2 | | 表記: | TESTOSTERONE HEMISUCCINATE | | 組成式: | C23 H32 O5 | | SMILES: | O=C(O)CCC(=O)OC2CCC1C4C(CCC12C)C3(C(=CC(=O)CC3)CC4)C | | InChi: | InChI=1S/C23H32O5/c1-22-11-9-15(24)13-14(22)3-4-16-17-5-6-19(23(17,2)12-10-18(16)22)28-21(27)8-7-20(25)26/h13,16-19H,3-12H2,1-2H3,(H,25,26)/t16-,17-,18-,19-,22-,23-/m0/s1 | | 別名: | 4-OXO-4-{[(8ALPHA,9BETA,10ALPHA,13ALPHA,14BETA,17ALPHA)-3-OXOANDROST-4-EN-17-YL]OXY}BUTANOIC ACID | | 定義日: | 2006-01-06 | | 最終更新日: | 2021-03-13 | | 識別子（ID）: | 4-oxo-4-{[(8alpha,10alpha,13alpha,14beta,17alpha)-3-oxoandrost-4-en-17-yl]oxy}butanoic acid |
|
 | | FFA | | 表記: | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | | 組成式: | C19 H28 O2 | | SMILES: | O=C4C=C3C(C2CCC1(C(CCC1O)C2CC3)C)(C)CC4 | | InChi: | InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17+,18-,19-/m0/s1 | | 別名: | EPI-TESTOSTERONE | | 定義日: | 2006-10-16 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one |
|
 | | 6VW | | 表記: | (8~{R},9~{S},10~{R},13~{S},14~{S},17~{S})-13-methyl-17-oxidanyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1~{H}-cyclop
enta[a]phenanthren-3-one | | 組成式: | C18 H26 O2 | | SMILES: | C[C]12CC[CH]3[CH](CCC4=CC(=O)CC[CH]34)[CH]1CC[CH]2O | | InChi: | InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1 | | 別名: | 19-nortestosterone | | 定義日: | 2016-07-06 | | 最終更新日: | 2020-06-17 | | 公開日: | 2016-09-07 | | 識別子（ID）: | (8~{R},9~{S},10~{R},13~{S},14~{S},17~{S})-13-methyl-17-oxidanyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1~{H}-cyclopenta[a]phenanthren-3-one |
|
 | | BDT | | 表記: | 5-beta-DIHYDROTESTOSTERONE | | 組成式: | C19 H30 O2 | | SMILES: | O=C2CC1CCC3C(C1(C)CC2)CCC4(C3CCC4O)C | | InChi: | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14+,15+,16+,17+,18+,19+/m1/s1 | | 別名: | (5beta,8alpha,17beta)-17-hydroxyandrostan-3-one | | 定義日: | 2008-07-15 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (5beta,8alpha,17beta)-17-hydroxyandrostan-3-one |
|
 | | B3J | | 表記: | (1S,2S)-2-{[N-({[4-benzyl-1-(tert-butoxycarbonyl)piperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | | 組成式: | C31 H48 N4 O10 S | | SMILES: | C(CC1CCNC1=O)(C(O)S(=O)(O)=O)NC(C(CC(C)C)NC(=O)OC3(Cc2ccccc2)CCN(CC3)C(OC(C)(C)C)=O)=O | | InChi: | InChI=1S/C31H48N4O10S/c1-20(2)17-23(26(37)33-24(27(38)46(41,42)43)18-22-11-14-32-25(22)36)34-28(39)44-31(19-21-9-7-6-8-10-21)12-15-35(16-13-31)29(40)45-30(3,4)5/h6-10,20,22-24,27,38H,11-19H2,1-5H3,(H,32,36)(H,33,37)(H,34,39)(H,41,42,43)/t22-,23-,24-,27-/m0/s1 | | 定義日: | 2017-07-31 | | 最終更新日: | 2020-05-27 | | 公開日: | 2018-04-04 | | 識別子（ID）: | (1S,2S)-2-{[N-({[4-benzyl-1-(tert-butoxycarbonyl)piperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | TES | | 表記: | TESTOSTERONE | | 組成式: | C19 H28 O2 | | SMILES: | O=C4C=C3C(C2CCC1(C(CCC1O)C2CC3)C)(C)CC4 | | InChi: | InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2011-06-04 | | 識別子（ID）: | (8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one |
|
 | | DHT | | 表記: | 5-ALPHA-DIHYDROTESTOSTERONE | | 組成式: | C19 H30 O2 | | SMILES: | O=C2CC1CCC3C(C1(C)CC2)CCC4(C3CCC4O)C | | InChi: | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2011-06-04 | | 識別子（ID）: | (5beta,8alpha,17beta)-17-hydroxyandrostan-3-one |
|
 | | BML | | 表記: | 4-BROMOPHENOL | | 組成式: | C6 H5 Br O | | SMILES: | Brc1ccc(O)cc1 | | InChi: | InChI=1S/C6H5BrO/c7-5-1-3-6(8)4-2-5/h1-4,8H | | 定義日: | 2004-04-29 | | 最終更新日: | 2011-06-04 | | 識別子（ID）: | 4-bromophenol |
|
